On the morning of March 6th, local time, at a hearing held by the Homeland Security and Government Affairs Committee of the United States Senate, the Senate version of the Biosafety Act (No. S.3558) was passed with an overwhelming majority of votes. The bill, proposed by Senator Gary Peters, aims to prohibit the US federal government from signing contracts with certain biotech providers associated with foreign competitors, including companies such as BGI and WuXi AppTec, which have been named.